Pan Tumor Nivolumab Rollover Study

Study Number
615220
Phase
II
Age Group
Adult
Principal Investigator
Saby George
Purpose

Main Objective of this study is to examine long-term safety of nivolumab in participants on treatment and in follow up.

Check your eligibility for this trial
Check now
Full Title

Pan Tumor Study for Long Term Follow-up of Cancer Survivors Who Have Participated in Trials Investigating Nivolumab

ClinicalTrials.Gov ID
NCT03899155

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.